Search

Search Constraints

You searched for: Author/Creator Roman, François

Search Results

1. An assessment of prime‐boost vaccination schedules with AS03A‐adjuvanted prepandemic H5N1 vaccines: a randomized study in European adults. Issue 1 (9th March 2012)

2. Efficacy of RTS, S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5–17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial. Issue 9 (September 2022)

4. Long-term incidence of severe malaria following RTS, S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial. Issue 8 (August 2019)

5. O2‐04‐03: MEMORY DEFICITS OF 5XFAD MICE IN THE OLFACTORY H‐MAZE TEST CORRELATE WITH PLAQUES DEVELOPMENT AND ARE PREVENTED BY 5‐HT4R AGONIST TREATMENTS. (1st July 2014)

6. Persistence of vaccine-elicited immune response up to 14 years post-HIV gp120-NefTat/AS01B vaccination. Issue 7 (11th February 2020)

7. Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study. Issue 3 (March 2016)

8. Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal. (8th November 2018)

9. Safety and immunogenicity of a SARS-CoV-2 recombinant protein nanoparticle vaccine (GBP510) adjuvanted with AS03: A randomised, placebo-controlled, observer-blinded phase 1/2 trial. (September 2022)

10. Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial. Issue 6 (June 2020)